Researchers at the University of Illinois at Chicago (UIC) College of Medicine have shown that the activation of a single cell provokes the inflammation and bone degradation of patients with rheumatoid arthritis (RA). The findings of the study may point to a new therapeutic target to interrupt the cycle of inflammation and bone erosion in RA.

Click Here to read more